The nation of Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential data.
This rejection came to light following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
A government representative later clarified that the United States was seeking health data for research and profit while refused to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to secure a deal suitable to all parties so the nation's critical HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
Based on reports, Sixteen nations in Africa have to date signed these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our population should a future pandemic arise."
Sovereignty and Global Health
He also pointed out that the American exit from the global health body and its push of bilateral deals were upending structures already set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent co-operation could be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks must proceed considering much of the nation's HIV programmes depended on international support.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it added.
This impasse underscores the ongoing challenges between accepting much-needed foreign assistance and protecting local interests in an ever more data-driven world.